Showing results (601-610 of 691) with videos related to

Sort By:
Pageof 70
Journal of Clinical Gastroenterology|October 26, 2016
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective StudyBrett E Fortune, Guadalupe Garcia-Tsao, Maria Ciarleglio, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
Journal of Hepatology|November 11, 2022
Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitisWei Shen, Michael S Middleton, Guilherme M Cunha, et al.
Hepatology (Baltimore, Md.)|August 1, 2021
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH CirrhosisJaime Bosch, Chuhan Chung, Oscar M Carrasco-Zevallos, et al.
Hepatology (Baltimore, Md.)|November 12, 2018
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver DiseaseYanling Ma, Olga V Belyaeva, Philip M Brown, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2022
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese IndividualsKai En Chan, Cheng Han Ng, Clarissa Elysia Fu, et al.
Scientific Reports|February 15, 2020
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver DiseaseVincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Journal of the American Heart Association|December 8, 2023
Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery DiseaseVardhmaan Jain, Anurag Mehta, Terence B Lee, et al.
Pageof 70